Pacini, M. F., Bulfoni Balbi, C., Dinatale, B., González, F. B., Prochetto, E. S., de Hernández, M. A., . . . Perez, A. R. (2023). Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity. Web
Citación estilo ChicagoPacini, María Florencia, et al. Intranasal Trans-sialidase-based Vaccine against Trypanosoma Cruzi Triggers a Mixed Cytokine Profile in the Nasopharynx-associated Lymphoid Tissue and Confers Local and Systemic Immunogenicity. 2023.
Cita MLAPacini, María Florencia, et al. Intranasal Trans-sialidase-based Vaccine against Trypanosoma Cruzi Triggers a Mixed Cytokine Profile in the Nasopharynx-associated Lymphoid Tissue and Confers Local and Systemic Immunogenicity. 2023.